FDA product code POY: Post Breast Biopsy Hemostatic Breast Compression Device

POY is the FDA product code for post breast biopsy hemostatic breast compression device. It is a Class II device, regulated under 21 CFR 892.1710 and reviewed by the General and Plastic Surgery panel. FDA has cleared 1 510(k) submission under POY. The average 510(k) review took 229 days (median 229).

Definition

To achieve and maintain hemostasis of a breast biopsy wound site.

Classification

FieldValue
Device namePost Breast Biopsy Hemostatic Breast Compression Device
Device classClass II
Regulation21 CFR 892.1710
Review panelSU — General and Plastic Surgery
Medical specialtyRadiology
Premarket route510(k)

510(k) clearances per year for POY

YearClearancesAvg. review days
20171229

Compare with all 510(k) review times · Search every POY clearance

Top POY applicants

ApplicantClearancesLatest
Xpress Bcd, LLC12017-07-19

Most recent POY clearances

510(k)ApplicantDeviceDecision dateReview days
K163388Xpress Bcd, LLCXPress BCD Breast Compression Device2017-07-19229

Recalls for POY devices

openFDA lists no recalls for product code POY.

Frequently asked questions

What is FDA product code POY?

POY is the FDA product code for post breast biopsy hemostatic breast compression device. It is a Class II device, regulated under 21 CFR 892.1710 and reviewed by the General and Plastic Surgery panel.

What device class is POY?

Class II, regulation 21 CFR 892.1710. Typical premarket route: 510(k).

How long does a 510(k) take for product code POY?

Across 1 cleared submissions the average was 229 days from receipt to decision (median 229).

Which companies have the most POY clearances?

Xpress Bcd, LLC (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All General and Plastic Surgery product codes · FDA product code lookup · 510(k) database search · 510(k) review times